Evolent Health
EVH
EVH
262 hedge funds and large institutions have $3.66B invested in Evolent Health in 2024 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 76 increasing their positions, 92 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.2% less ownership
Funds ownership: 111.57% → 111.37% (-0.2%)
10% less call options, than puts
Call options by funds: $75.4M | Put options by funds: $84.2M
17% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 92
Holders
262
Holding in Top 10
7
Calls
$75.4M
Puts
$84.2M
Top Buyers
| 1 | +$51.7M | |
| 2 | +$36.8M | |
| 3 | +$36.7M | |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$32.8M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$25.8M |
Top Sellers
| 1 | -$51.7M | |
| 2 | -$46.2M | |
| 3 | -$30.8M | |
| 4 |
Holocene Advisors
New York
|
-$26.6M |
| 5 |
O
OrbiMed
New York
|
-$24.2M |